LIVE Virtual Training Course: INTRODUCTION TO ANTIBODY ENGINEERING
14-16 April 2021 | 9:00 am - 11:30 am JST (Japan Standard Time) |
13-15 April 2021 | 8:00 - 10:30 pm EST | 5:00 - 7:30 pm PST
Whether you need a refresher on antibody engineering concepts and applications, are new to the field or have new responsibilities in antibody/protein engineering & therapeutics-related department, you will find this popular course extremely helpful!
Delivered over 3 days in easily digestible 2.5-hour modules, the knowledge gained from this comprehensive training course is invaluable!
Want to train your entire team? Contact Jessica Purnell for information about affordable company license options at Jessica.Purnell@informa.com or call: +44 (0)20 7551 9521.
Space is limited so be sure to register early!
Training course will be recorded. You will be able to access the recordings after the event is over in case you miss any of the sessions.
Today’s wealth of knowledge of protein structures will be reviewed along with the genetics of diversity generation of antibodies, to give insights into the best strategies for improving protein function. There is particular emphasis on the choice of a functional assay to monitor effectively the changes in a desired property, and the use of functional enrichment steps where a library approach is employed. Not only is amino acid sequence amenable to may also be engineered. The course will focus on the engineering and enhancement of antibodies and antibody-like scaffolds. Examples will include work on antibody by diverse approaches and the adaptation to generate Chimeric Antibody Receptor (CAR) constructs will be discussed. Expression platforms for producing antibodies for testing and for manufacture will also be covered. A background in biochemistry and molecular biology is useful, as the course is designed to progress rapidly from simple to advanced concepts.
Topics Covered Include:
Topics Covered Include:
- Functions amenable to engineering: Affinity, specificity, stability, solubility, immunogenicity
- The measure of success: functional assays
- Engineering by design
- Engineering by random mutation
- Immunogenicity engineering
- Antibody-drug conjugates (ADCs)
- CAR-T strategies
- Designed libraries
- Expression of antibodies and fragments for discovery
- Display technologies
- Improving manufacturing by protein engineering methods
- Glycosylation engineering – function and homogeneity
Meet the Instructor
Dave Bramhill, Ph.D., helped establish the Merck antibody discovery and development department. He has had responsibilities in several vaccine development projects at Merck and as a consultant more recently. He has advised multiple start-up companies developing novel chemistries and enzymatic strategies for bioconjugation, applied to ADCs, peptides and other products.
Additional Date: 1-3 June 2021
If timing doesn't suit your schedule, this training course will also be delivered on 1-3 June 2021 in British Summer Time. To find out more, click on the button below.